Tumor infiltrating lymphocytes engineered with membrane-bound IL-15
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Tumor infiltrating lymphocytes engineered with membrane-bound IL-15, covering 2026-04-16 to 2026-04-16. Get the full timeline:
Most recent: Clinical Trial Update: Phase I, Open-Label, Study of Tumor Infiltrating Lymphocytes Engineered With Membrane Bound IL15 Plus Acetazolamide in Adult Patients With Metastatic Melanoma [Phase 1]